High-purity phytochemical standards and diagnostic formulation reagents sourced directly from our GMP-compliant extraction facility.
Direct Bilirubin (often referred to as D Bilirubin) is a physiological biomarker of immense diagnostic significance. Synthesized in the hepatocyte pathways via the conjugation of free bilirubin with glucuronic acid, direct bilirubin is soluble in water and excreted through the biliary tree. When clinical diagnostic systems indicate "D Bilirubin High" (Conjugated Hyperbilirubinemia), it points directly to underlying pathologies such as biliary obstruction, cholestasis, hepatocellular damage, or genetic transport deficiencies like Dubin-Johnson and Rotor syndromes.
For global in-vitro diagnostics (IVD) manufacturers, sourcing highly stable, ultra-pure chemical standards and enzyme modifiers is vital for producing accurate assay kits. Without precise assay components, diagnostic tests suffer from cross-reactivity and drift, leading to false positives in patient liver function panels. Chengdu Chenlv Herb Co., Ltd. addresses this crucial B2B demand by manufacturing pharmaceutical-grade active ingredients, diagnostic stabilizers, and plant-derived enzymatic regulators that serve as critical components in clinical reagents and hepatoprotective formulations.
"Diagnostic precision in hepatology relies on chemical integrity. Our OEM/ODM D-Bilirubin assay component pipelines are engineered to provide maximum batch consistency, maintaining stable enzymatic pathways even under fluctuating shipping conditions."
The global diagnostics market is undergoing a structural transition toward high-sensitivity quantitative assays. The demand for Direct Bilirubin testing is rising steadily, driven by the global increase in non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), and general gallbladder diseases. Healthcare providers require point-of-care (POC) biochemical analyzers that deliver rapid, laboratory-grade results.
Concurrently, the therapeutic side is experiencing a surge in demand for natural liver-protection agents. B2B buyers in the pharmaceutical and nutraceutical sectors are focusing heavily on ingredients like Ursodeoxycholic Acid (UDCA), Sodium Dehydrocholate, and high-potency botanical extracts (such as silymarin, licorice root derivatives, and methyl-hesperidin) to formulate therapies that manage bile flow and mitigate high bilirubin concentrations.
For procurement officers representing international pharmaceutical brands and IVD manufacturers, procuring raw ingredients is not merely about finding a competitive pricelist. It requires sourcing from a partner that guarantees regulatory compliance, traceabile raw materials, and robust quality control. Sourcing teams look for facilities verified by recognized standards like ISO9001, ISO22000, KOSHER, HALAL, and registered with the FDA to ensure hassle-free global customs clearance and formulation safety.
Harnessing smart manufacturing and automation to secure global supply chains and stabilize raw material costs.
In an era characterized by geopolitical shifts and logistics uncertainty, Chengdu Chenlv Herb Co., Ltd. has integrated the concepts of "China Factory 4.0" into its extraction facilities. By employing automated closed-loop extraction lines, real-time chromatographical monitoring, and continuous-flow production systems, we maintain stable production outputs while minimizing human error and environmental footprint.
This digitization of our factory floor ensures that every batch of plant extract—whether it is Pomegranate Peel Extract, Sodium Dehydrocholate, or Ursodeoxycholic Acid—conforms precisely to the chemical specifications agreed upon during the contract design stage. Our facility features advanced high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) labs to test raw material inputs prior to extraction, ensuring zero pesticide or heavy metal residues pass through to the final formulation.
Choose Chenlv Herb for products that deliver beyond expectations.
Chenlv Herb provides one-stop contract manufacturing services customized for global laboratory and health brands.
Communicate with customers to determine product specifications and purity requirements.
Provide a comprehensive proposal and competitive price list based on target active ingredients.
Sign a contract to further discuss the details of cooperation, payment, and delivery timeline.
Make and distribute samples for laboratory verification and chemical assay alignment.
After customers confirm the samples, the factory schedules the bulk production order in cleanrooms.
The factory tests the finished batch and issues a Certificate of Analysis (COA).
Deliver the verified finished products directly to customer warehouses internationally.
Serving global industries through high-purity natural extracts and specialized physiological compounds.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for health care products due to their natural, green, and safe characteristics.
Read More
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy a prominent position in the pharmaceutical industry due to their active components and unique pharmacological effects.
Read More
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new skin solutions.
Read More
Plant extracts have shown great potential in improving animal health, enhancing production performance, and optimizing culture benefits, and are gradually becoming a research hotspot in animal nutrition.
Read MoreOur facility operates under rigorous international quality protocols. We are fully certified to service global markets.
Insights from our R&D team and updates from international biotechnology conferences.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end, price fluctuations have become a focal point.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with key machinery exhibitors.
Join Chengdu Chenlv Herb Co., Ltd. at the 92nd API Conference to explore how automated bio-extraction is changing the efficiency of global natural medicine active ingredients.
Get answers to technical, logistics, and quality questions related to Direct Bilirubin testing components and plant-based active pharmaceutical ingredients.
Additional custom extracts formulated for clinical research, dietary supplements, and therapeutic applications.
